Clinical Trial Update: A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This is a status update for an ongoing Phase I/II trial of XZP-3287 in metastatic solid tumors and advanced breast cancer, currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• XZP-3287

Snippet

Sponsor: Sihuan Pharmaceutical Holdings Group Ltd. | Conditions: Metastasis Solid Tumors, Advanced Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING